During the past decade, Advanced Clinical Research conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 44 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 27 clinical trials were completed. i.e. 96.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Clinical Research" #1 sponsor was "Pfizer" with 13 trials, followed by "Allergan" with 6 trials sponsored, "Celgene" with 4 trials sponsored, "Janssen Vaccines & Prevention B.V." with 4 trials sponsored and "Takeda" with 4 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Clinical Research" #1 collaborator was "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "COUR Pharmaceuticals Development Company, Inc." with 1 trials as a collaborator, "Chattem, Inc." with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Clinical Research" are "Crohn Disease" (4 trials), "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Influenza, Human" (3 trials) and "Osteoarthritis" (3 trials). Many other conditions were trialed in "Advanced Clinical Research" in a lesser frequency.

Most popular intervention types in "Advanced Clinical Research" are "Drug" (60 trials), "Biological" (37 trials), "Other" (9 trials), "Device" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (45 trials), "Ozanimod" (3 trials), "Relamorelin" (3 trials), "Ad26.COV2.S" (2 trials) and "Atogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Clinical Research" are 89 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Advanced Clinical Research". undefined are not yet recruiting, 5 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Advanced Clinical Research, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Clinical Research, 3 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".